Skip to main content

Peer Review reports

From: Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India

Original Submission
25 Sep 2020 Submitted Original manuscript
30 Sep 2020 Author responded Author comments - YOJANA gokhale
Resubmission - Version 2
30 Sep 2020 Submitted Manuscript version 2
13 Nov 2020 Reviewed Reviewer Report
4 Dec 2020 Reviewed Reviewer Report - Andree Kurniawan
16 Dec 2020 Author responded Author comments - YOJANA gokhale
Resubmission - Version 3
16 Dec 2020 Submitted Manuscript version 3
24 Dec 2020 Reviewed Reviewer Report - Andree Kurniawan
16 Jan 2021 Reviewed Reviewer Report
25 Jan 2021 Author responded Author comments - YOJANA gokhale
Resubmission - Version 4
25 Jan 2021 Submitted Manuscript version 4
1 Feb 2021 Author responded Author comments - YOJANA gokhale
Resubmission - Version 5
1 Feb 2021 Submitted Manuscript version 5
4 Feb 2021 Author responded Author comments - YOJANA gokhale
Resubmission - Version 6
4 Feb 2021 Submitted Manuscript version 6
10 Feb 2021 Author responded Author comments - YOJANA gokhale
Resubmission - Version 7
10 Feb 2021 Submitted Manuscript version 7
12 Feb 2021 Author responded Author comments - YOJANA gokhale
Resubmission - Version 8
12 Feb 2021 Submitted Manuscript version 8
Publishing
16 Feb 2021 Editorially accepted
5 Mar 2021 Article published 10.1186/s12879-021-05912-3

You can find further information about peer review here.

Back to article page